On April 14, S&P Global officially released the Sustainability Yearbook 2026 (China Edition), and JiuZhou Pharma was included in the yearbook.

S&P Global was founded in 1925 and is a leading global provider of financial data and information services. The Sustainability Yearbook (China Edition) is an ESG selection report published by S&P Global, aiming to recognize Chinese companies' performance in environmental, social, and corporate governance (ESG). This report's selections are based on companies' 2025 Corporate Sustainability Assessment (CSA) scores, covering 1,800 Chinese companies, with 190 ultimately selected (a selection rate of approximately 10.56%).

JiuZhou Pharma adheres to four pillars for sustainable development: building a governance system for robust operations, providing one-stop pharmaceutical innovation solutions, creating a development model of shared prosperity, and practicing a green and sustainable action philosophy. The company has fully integrated the concept of sustainable development into its strategy, major decision-making, daily operations, and employee management.

Being included in S&P Global’s Sustainability Yearbook 2026 (China Edition) is a significant encouragement for JiuZhou Pharma’s efforts in sustainable development. Going forward, we will continue to uphold the corporate mission of "caring for life, protecting health" and fulfill our sustainable development commitments through concrete actions.

On April 14, S&P Global officially released the Sustainability Yearbook 2026 (China Edition), and JiuZhou Pharma was included in the yearbook.

S&P Global was founded in 1925 and is a leading global provider of financial data and information services. The Sustainability Yearbook (China Edition) is an ESG selection report published by S&P Global, aiming to recognize Chinese companies' performance in environmental, social, and corporate governance (ESG). This report's selections are based on companies' 2025 Corporate Sustainability Assessment (CSA) scores, covering 1,800 Chinese companies, with 190 ultimately selected (a selection rate of approximately 10.56%).

JiuZhou Pharma adheres to four pillars for sustainable development: building a governance system for robust operations, providing one-stop pharmaceutical innovation solutions, creating a development model of shared prosperity, and practicing a green and sustainable action philosophy. The company has fully integrated the concept of sustainable development into its strategy, major decision-making, daily operations, and employee management.

Being included in S&P Global’s Sustainability Yearbook 2026 (China Edition) is a significant encouragement for JiuZhou Pharma’s efforts in sustainable development. Going forward, we will continue to uphold the corporate mission of "caring for life, protecting health" and fulfill our sustainable development commitments through concrete actions.

On April 14, S&P Global officially released the Sustainability Yearbook 2026 (China Edition), and JiuZhou Pharma was included in the yearbook.

S&P Global was founded in 1925 and is a leading global provider of financial data and information services. The Sustainability Yearbook (China Edition) is an ESG selection report published by S&P Global, aiming to recognize Chinese companies' performance in environmental, social, and corporate governance (ESG). This report's selections are based on companies' 2025 Corporate Sustainability Assessment (CSA) scores, covering 1,800 Chinese companies, with 190 ultimately selected (a selection rate of approximately 10.56%).

JiuZhou Pharma adheres to four pillars for sustainable development: building a governance system for robust operations, providing one-stop pharmaceutical innovation solutions, creating a development model of shared prosperity, and practicing a green and sustainable action philosophy. The company has fully integrated the concept of sustainable development into its strategy, major decision-making, daily operations, and employee management.

Being included in S&P Global’s Sustainability Yearbook 2026 (China Edition) is a significant encouragement for JiuZhou Pharma’s efforts in sustainable development. Going forward, we will continue to uphold the corporate mission of "caring for life, protecting health" and fulfill our sustainable development commitments through concrete actions.